• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WANG Qi-zhi, LIANG Jing-yu, FENG Xu. X-ray crystallographic analysis and revision of NMR spectral assignments for rhetsinine[J]. Journal of China Pharmaceutical University, 2009, 40(6): 503-505.
Citation: WANG Qi-zhi, LIANG Jing-yu, FENG Xu. X-ray crystallographic analysis and revision of NMR spectral assignments for rhetsinine[J]. Journal of China Pharmaceutical University, 2009, 40(6): 503-505.

X-ray crystallographic analysis and revision of NMR spectral assignments for rhetsinine

More Information
  • Rhetsinine has been isolated from the fruits of Evodia rutaecarpa(Juss.) Benth. 1H NMR and 13C NMR assignments reported previously for rhetsinine were revised on the basis of UV,IR,ESI-MS,1H NMR,13C NMR and X-ray crystallographic analysis.
  • Related Articles

    [1]CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
    [2]SUN Xiaofeng, LIU Tao, LING Yun, CHEN Zhengwei, PAN Zihao, XU Zite, LUO Ling. Advances in research of hyaluronic acid modified nanomicelles for targeting tumor therapy and drug release behavior[J]. Journal of China Pharmaceutical University, 2019, 50(6): 641-647. DOI: 10.11665/j.issn.1000-5048.20190602
    [3]WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501
    [4]WANG Letian, WANG Jinglin, LIU Hongwu, GE Ying, LI Yuyan, XU Qingxiang. Process in targeted contrast agents for cancer imaging[J]. Journal of China Pharmaceutical University, 2017, 48(6): 635-645. DOI: 10.11665/j.issn.1000-5048.20170602
    [5]LU Xiaolin, ZHENG Ying, QIU Yang, ZHOU Xiang, LU Tao. Small conjugate-based theranostic agents:a tumour microenvironment responsive approach for cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(6): 629-638. DOI: 10.11665/j.issn.1000-5048.20160601
    [6]ZHAO Yuekui, TANG Shanshan, ZHANG Yanfeng, ZONG Li, JIN Liang. Engineered mesenchymal stem cells as targeting therapeutic carriers in cancer therapy[J]. Journal of China Pharmaceutical University, 2016, 47(2): 134-139. DOI: 10.11665/j.issn.1000-5048.20160202
    [7]WANG Zhiqiang, WANG Xuemin, ZHANG Wei, WANG Xinyang, LING Yong, CHEN Li. Synthesis and biological evaluation of novel farnesylthiosalicylic acid/hydro-xylcinnamic acid hybrids as potential antitumor agents[J]. Journal of China Pharmaceutical University, 2014, 45(4): 392-399. DOI: 10.11665/j.issn.1000-5048.20140402
    [8]CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206
    [9]LI Linhu, CHEN Li, XIA Yufeng. Progress in the study of coumarin derivatives as antitumor agents[J]. Journal of China Pharmaceutical University, 2013, 44(4): 374-379. DOI: 10.11665/j.issn.1000-5048.20130417
    [10]Cooperative Effects of Monkshood Polysaccharide with Adriamycin Magnetic Albumin Microsphere Targeting Therapy on Tumor[J]. Journal of China Pharmaceutical University, 2003, (6): 68-72.

Catalog

    Article views (1089) PDF downloads (1453) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return